AAMU
TWST icon

Amundi Asset Management US’s Twist Bioscience TWST Stock Holding History

Amundi Asset Management US’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$341K Sell
2,753
-1,247
-31% -$189K ﹤0.01% 1386
2020
Q4 		$565K Hold
4,000
– – ﹤0.01% 1276
2020
Q3 		$304K Buy
+4,000
New +$249K ﹤0.01% 1324

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Amundi Asset Management US's TWST Position: Q1 2021 in Review

Amundi Asset Management US reduced its Twist Bioscience (TWST) stake by 31% in Q1 2021, selling an estimated $189K and leaving 2,753 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Amundi Asset Management US first reported a position in TWST in Q3 2020 and has held it in 3 quarters since. The position peaked at $565K in Q4 2020. 240 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

  • Amundi Asset Management US held 2,753 shares of Twist Bioscience worth $341K as of Q1 2021.
  • Amundi Asset Management US sold 1,247 Twist Bioscience shares in Q1 2021, an estimated $189K.
  • Twist Bioscience made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1386 holding.
  • Amundi Asset Management US first reported a position in Twist Bioscience in Q3 2020 and has held it in 3 quarters since.
  • Amundi Asset Management US's Twist Bioscience position peaked at $565K in Q4 2020.
  • 240 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.